Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

IPO-38 Antibody (SPM515) - IHC-Prediluted, Novus Biologicals™
SDP

Catalog No. NBP248301 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
7 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP248301 7 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP248301 Supplier Novus Biologicals Supplier No. NBP248301
Add to Cart
Add to Cart

Mouse Monoclonal Antibody

IPO-38 Monoclonal specifically detects IPO-38 in Human, Mouse, Rat samples. It is validated for Immunohistochemistry, Immunohistochemistry-Paraffin.

Specifications

Antigen IPO-38
Applications Immunohistochemistry (Paraffin)
Classification Monoclonal
Clone SPM515
Conjugate Unconjugated
Dilution Immunohistochemistry-Paraffin
Formulation 10mM PBS and 0.05% BSA with 0.05% Sodium Azide
Host Species Mouse
Immunogen Spleen cells of a patient with hairy cell leukemia
Purification Method Protein L or PEG purified
Quantity 7 mL
Regulatory Status RUO
Primary or Secondary Primary
Test Specificity Recognizes a protein of 14-16kDa, which is a novel nuclear antigen of proliferating cells. IPO-38 antigen is present in the nuclei of proliferating cells such as Hodgkin s disease and non-Hodgkin s lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO-38 can be a useful marker of cell proliferation during monitoring of tumor progression.
Target Species Human, Mouse, Rat
Content And Storage Store at 4C.
Form Purified
Isotype IgM κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.